La bourse est fermée

IQVIA Holdings Inc. (IQV)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
261,61-0,66 (-0,25 %)
À la clôture : 4:04PM EDT

IQVIA Holdings Inc.

83 Wooster Heights Road
Danbury, CT 06810
United States
203 448 4600
http://www.iqvia.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein74 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Ari BousbibChairman, Pres & CEO8,76M61,14M1961
Mr. Ronald E. BruehlmanExec. VP & CFO1,67MS.O.1961
Mr. Kevin C. KnightlyPres of Technology & Commercial Solutions1,23MS.O.1961
Mr. Eric M. SherbetExec. VP, Gen. Counsel & Sec.1,24MS.O.1964
Mr. W. Richard Staub IIIPres of R&D Solutions1,45M4,05M1963
Mr. Emmanuel N. KorakisSr. VP, Corp. Controller & Principal Accounting OfficerS.O.S.O.1974
Dr. Jeffrey A. SpaederSr. VP, Global Chief Medical & Scientific OfficerS.O.S.O.S.O.
Mr. Alejandro MartinezChief Information OfficerS.O.S.O.S.O.
Andrew MarkwickSr. VP of Investor Relations & TreasuryS.O.S.O.S.O.
Mr. Nicholas ChildsSr. VP, Investor Relations & Corp. CommunicationsS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2020 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. IQVIA has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Gouvernance d’entreprise

L’ISS Governance QualityScore de IQVIA Holdings Inc. en date du 1 juillet 2021 est 10. Les scores principaux sont Audit : 5; Société : 10; Droits des actionnaires : 9; Compensation : 10.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.